Skip to main content
Log in

Renal tubular dysgenesis associated with in utero exposure to Nimuselide

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Maternal ingestion of the selective cyclo-oxygenase-2 (COX-2) inhibitor Nimuselide has been reported to be associated with the development of oligohydramnios and neonatal renal failure in some cases. We report a case of neonatal renal failure associated with maternal ingestion of Nimuselide in the third trimester of pregnancy. The neonate presented with metabolic acidosis and non-oliguric renal failure on the second day of life. The renal histopathology showed evidence of renal tubular dysgenesis. The child continues to have elevated serum creatinine and hypertension at 10 months of age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Peruzzi L, Gianoglio B, Porcellini MG, Coppe R (1999) Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase type 1 selective inhibitor nimuselide as tocolytic. Lancet 354:1615

    Article  PubMed  Google Scholar 

  2. Balasubramanian J (2000) Nimuselide and neonatal renal failure. Lancet 355:575

    Article  Google Scholar 

  3. Holmes RP, Stone PR (2000) Severe oligohydramnios induced by cyclooxygenase 2 inhibitor nimuselide. Obstet Gynecol 96:810–811

    Article  PubMed  Google Scholar 

  4. Dinchuk JE, Car BD, Fochet RJ, Johnston JJ, Jaffe BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM (1995) Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378:406–409

    Article  PubMed  Google Scholar 

  5. Zhang MZ, Wang JL, Chang HF, Harris RC, Mc Kamna JA (1997) COX-2 in rat nephron development. Am J Physiology 273:F994–F1002

    Google Scholar 

  6. Allanson JE, Hunter AGW, Mettler GS, Jimenez C (1992) Renal tubular dysgenesis: not an uncommon autosomal recessive syndrome. A review. Am J Med Genet 43:811–814

    Article  PubMed  Google Scholar 

  7. Pryde PG, Sedman AB, Nugent CE, Barr M Jr (1993) Angiotensin converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575–1582

    PubMed  Google Scholar 

  8. Kaplan BS, Restaino I, Raval DS, Gottlieb RB, Bernstein J (1994) Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory drugs. Pediatr Nephrol 8:700–704

    Article  PubMed  Google Scholar 

  9. Voyer LE, Drut R, Mendez JH (1994) Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam. Pediatr Nephrol 8:592–594

    Article  PubMed  Google Scholar 

  10. Benini D, Fanos V, Cuzzolin L, Tato L (2004) In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 19:232–234

    Article  PubMed  Google Scholar 

  11. Oberg KC, Pestaner JP Bielamosicz L, Hawkins EP (1999) Renal tubular dysgenesis in twin–twin transfusion syndrome. Pediatr Dev Pathol 2:25–32

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uma Sankari Ali.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ali, U.S., Khubchandani, S., Andankar, P. et al. Renal tubular dysgenesis associated with in utero exposure to Nimuselide. Pediatr Nephrol 21, 274–276 (2006). https://doi.org/10.1007/s00467-005-2089-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-005-2089-0

Keywords

Navigation